The effect of steroids on Dupuytren's disease: Role of programmed cell death

Journal of Hand Surgery

Volumn 27 B, Issue 3, 2002, Pages 270-273

  Meek, R M D ^a   McLellan, S ^a   Reilly, J ^a   Crossan, J F ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; KI 67 ANTIGEN; METHYLPREDNISOLONE ACETATE; STEROID;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECOMPRESSION SURGERY; DRUG EFFECT; DUPUYTREN CONTRACTURE; FASCIA LATA; FEMALE; FIBROBLAST CULTURE; HAND PALM; HUMAN; HUMAN CELL; INFLAMMATORY CELL; INJECTION; MALE; MYOFIBROBLAST; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SKIN NODULE;

EID: 0036332766     PISSN: 02667681     EISSN: None     Source Type: Journal    
DOI: 10.1054/jhsb.2001.0742     Document Type: Article

References (22)

1. An investigation into the role of inflammatory cells in Dupuytren's disease
2. T-cell-mediated response in Dupuytren's disease
3. Abnormal growth factor and cytokine expression in Dupuytren's contracture
4. Aetiopathogenesis of Dupuytren's disease
5. Factors influencing myofibroblast differentiation during wound healing and fibrosis
6. Epithelioid sarcoma masquerading as Dupuytren's disease
7. Dupuytren's disease
8. Le(y) antigen expression is correlated with apoptosis (programmed cell death)
9. Is Dupuytren's disease caused by an imbalance between cell proliferation and cell death
10. The effect of 5-fluorouracil on Dupuytren's fibroblast proliferation and differentiation
11. The injection of nodules of Dupuytren's disease with triamcinolone acetonide
12. Recurrence in Dupuytren's disease
13. Tumour-necrosis-factor-induced fibroblast growth factor -1 acts as a survival factor in a transformed endothelial cell line
14. Apoptosis in human monocytes: Possible role in chronic inflammatory disease
15. A model for the mechanism of fibrosis and its modulation by steroids
16. An insight into Dupuytren's contracture
17. Reactivity of nodular cells in vitro: A guide to the pharmacological treatment of Dupuytren's contracture
18. Which proliferative marker for routine immunohistochemistry? A comparison of five antibodies
19. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages
20. NOC, a nitric oxide releasing compound, induces dose dependent apoptosis in macrophages
21. Cellular structure and biology of Dupuytren's disease
22. Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway